These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 18339451

  • 1. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.
    Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M.
    Neurobiol Aging; 2009 Nov; 30(11):1834-41. PubMed ID: 18339451
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
    Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira CR.
    J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
    [Abstract] [Full Text] [Related]

  • 3. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
    Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ.
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
    [Abstract] [Full Text] [Related]

  • 4. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
    Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR.
    J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
    [Abstract] [Full Text] [Related]

  • 5. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
    Hermann P, Haller P, Goebel S, Bunck T, Schmidt C, Wiltfang J, Zerr I.
    Viruses; 2022 Jan 28; 14(2):. PubMed ID: 35215868
    [Abstract] [Full Text] [Related]

  • 6. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
    Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR.
    Neuroscience; 2016 May 13; 322():398-407. PubMed ID: 26940479
    [Abstract] [Full Text] [Related]

  • 7. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.
    Gmitterová K, Heinemann U, Krasnianski A, Gawinecka J, Zerr I.
    Eur J Neurol; 2016 Jun 13; 23(6):1126-33. PubMed ID: 27029507
    [Abstract] [Full Text] [Related]

  • 8. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F, Zafar S, Ansoleaga B, Shafiq M, Blanco R, Carmona M, Grau-Rivera O, Nos C, Gelpí E, Del Río JA, Zerr I, Ferrer I.
    Neuropathol Appl Neurobiol; 2015 Aug 13; 41(5):631-45. PubMed ID: 25134744
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.
    Zanusso G, Fiorini M, Ferrari S, Gajofatto A, Cagnin A, Galassi A, Richelli S, Monaco S.
    Int J Mol Sci; 2011 Aug 13; 12(9):6281-92. PubMed ID: 22016658
    [Abstract] [Full Text] [Related]

  • 10. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
    Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, Rossi M, Baiardi S, McGuire L, Ladogana A, Pocchiari M, Green A, Capellari S, Parchi P.
    Acta Neuropathol; 2017 Apr 13; 133(4):559-578. PubMed ID: 28205010
    [Abstract] [Full Text] [Related]

  • 11. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.
    Sanchez-Juan P, Sánchez-Valle R, Green A, Ladogana A, Cuadrado-Corrales N, Mitrová E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Krasnianski A, Equestre M, Slivarichová D, Saiz A, Calero M, Pocchiari M, Knight R, van Duijn CM, Zerr I.
    J Neurol; 2007 Jul 13; 254(7):901-6. PubMed ID: 17385081
    [Abstract] [Full Text] [Related]

  • 12. Mitochondrial DNA differentiates Alzheimer's disease from Creutzfeldt-Jakob disease.
    Podlesniy P, Llorens F, Golanska E, Sikorska B, Liberski P, Zerr I, Trullas R.
    Alzheimers Dement; 2016 May 13; 12(5):546-55. PubMed ID: 26806388
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis.
    Gawinecka J, Ciesielczyk B, Sanchez-Juan P, Schmitz M, Heinemann U, Zerr I.
    Neurodegener Dis; 2012 May 13; 9(3):139-44. PubMed ID: 22213780
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S, Zakova Slivarichova D, Tomeckova I, Melicherova K, Stelzer M, Janakova A, Kosorinova D, Belay G, Mitrova E.
    Mol Neurobiol; 2017 Oct 13; 54(8):5919-5927. PubMed ID: 27665282
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.
    Karch A, Hermann P, Ponto C, Schmitz M, Arora A, Zafar S, Llorens F, Müller-Heine A, Zerr I.
    Neurobiol Aging; 2015 May 13; 36(5):1964-8. PubMed ID: 25749129
    [Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B, Boons J, Cras P.
    Clin Neurol Neurosurg; 2005 Aug 13; 107(5):355-60. PubMed ID: 16023527
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.